Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1BeVF6UE12VXFqcHlRWUU0QzZEZm1CWHFyMkpHX3B5RFgxbFc1TW5ob3k2VGp2VkY3TEpmcHJPeHpUemtFS3lJZnFTTXJoSWtxVE5tVEQ4UnNXa09mZWlzUGtTejBsMThJTllpMUhSOUZOQQ?oc=5" target="_blank">Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
Arsenal v Lille: Champions League – live
Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief
Bears DE Montez Sweat suspended 2 days for drug violation
Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1GSTIwSFJ5WjRtNVJ2Vk1EOVNGekxLRnFWT2lGMFd0SXgyUlROdldJUlNwQWJMR2tjQ25RYlF5MzcySk9XQXZ6dEt4OTdQUmxTc09MbEJZZEQ4R1dkZXM4Rw?oc=5" target="_blank">Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBId3dad1ZGRVVtLWx2RzNtYktxVVgzUUxfTUthNHBzRFRaU0tycFBzOHh6dlNHRGVSMFZ0dlloc2VkNFQ4enBYZmZQNTlMZWtNYjh5bFVldDYxZ2JYSnVJ?oc=5" target="_blank">Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBMcHVrUms0VXRHRnJqcDBUUjhDNmIzT1NDN3dRb0ZxTXpWUDRubkNZMXVGdGlJclVTbmprRHgwM3g2cHp2akFPdzRlOU04X3VQeXhsOU80aV9URlVBUzlVSA?oc=5" target="_blank">Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tWVFvbDY1WDR4SWVoWWV0V0lvRHF6bktIUy1meC00d3lFVXZJQVRZNm94NDVoRFVyZk50M3NhTm1MaThJWmZXNVU2S0NLX2NGRmF3ZzQ2b0IwUWQ0MXVr?oc=5" target="_blank">Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine</a>&nbsp;&nbsp;<font color="#6f6f6f">Science | AAAS</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CcGIwQXQ4V3FTWjFNeWdpNXIyMFRTTmtDTGZCRWNkSS12QlBwV0RrR2hrTE4zMFhQaC04dWpvRHRmMS11ZDlLTFRxTjhuOFhTTE1EaVhtVzh4VXRPYmdV?oc=5" target="_blank">Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPV0R0by1CeDl3Rm9JQnhRemlwZGJZaHphVVVweUZreDJoMVhBbW1NSDJaMHpmdTUzLXZqNTVQTlVxQUVnbTN3MGF3dDNxTU0yd0FzMVRsT3lBMWQ1MW5CUlJ3a0pRbFh3ZGFlMmI4UWdfTnl2Ym5ybGZ3aXVCWFh2cEhvck5La2RZRmRr?oc=5" target="_blank">Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE56TVJSWDMteFN6OUloRkxaeFdXSFRycW5ZSWhibXB1Vi1JM1JRWkJwSmxaRDQyUW1aYjNqMUV2RTY4QmZHUEV6U29hcDJBUndqaDdKSHZ6R0VlTHhjanVv?oc=5" target="_blank">Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9RTnBvdnVwTVlGVDU5UnlqaTl0R1pscE51bDlRNHJpVVlLRW12U254RmRXalFmQ3N4NE5mWW1SZU5YNkk0cmZ2V0pwelNnNXd1bGNfeXdZTzRyMXVzdV96dw?oc=5" target="_blank">Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTzN0NVdIZzg4WDRuWkFneUZtS2xmc0E2N3NDd2hEdDNrQkxWMGVNR3M5QU52c2JHNmY0Y1hpTzdqdktmNHRTdmtzS3p2Ql8wR1FxR2ZtMTNsbnNEQk9EMldiUllXNGZRR0hvbUZ4VE03NF9BUWFOZHFmd3gxSUp0b2k0TGw1RVQ3Umww?oc=5" target="_blank">Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43THB2YlphdnduYVdwMDJSbGVCc0xRRFdfU1VLbjRSa0JlTTZEMmNKWFRtZndjUEFxTDQ3Nk5NM1ZvUWN2U3BjWnd5cDE2RjdkRWtlb2F3d19zbmRVWkRz?oc=5" target="_blank">Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study | Signal Transduction and Targeted Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE10YWxMV2JmMDVMRkVYVHdERl9IZzNiT19QWkJGMmRKYlE1SkRnem1zU0VRalNGdUx0NU1BOUphVHlNNmY4SWNpN05PM0xyR1RDTVhzOGlyUU03Vk16aGxTWA?oc=5" target="_blank">Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOVThEZWxKcndoTGRHWEpRY09ZV0swLThFOGJkTG5zMFpUT0RzbFZlcm5kV01UZVhaZGU3NUlzdWVHcHViWlZGanJBSVgzZ2Z6UUNHYkQxRXFWcUlHTmk3M1lveTZQQWJxR0EzOFctc1RHWnRqdUhtcUZOR1dVdGRfTlJ2U3ZqM0ZpQXU0?oc=5" target="_blank">Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GdF9zaEM4QVhnY01HQVM4SWFGQ1hhRmE4TjVsOFVwaVdSYnc5TGJOWHMxWEczX3BMZmhwLU1VOXpKUXQtX1RFbm1IZHdJVG5rWUc5ZGFIZ1ZQdlJ2NENj?oc=5" target="_blank">Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE14aFlPbnFGRzEycnlfN2ozUUVwdjl5dV9mTm5RMW5IQ3NEM3BWZENqcjN2RlZjNVpSbEtKV1Bsem1TX3RDTkdvV0I3Y2FmaEowT0tOMUdtOUxwTFV3THJJ?oc=5" target="_blank">Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2VWxtb0kwbG51VGNfaGQtZ3puUGpaaGNuUzRmeFFtaU9ITUozekRBbE9EUTFQc3Y2ZzJoUTJYN2p4QTFLNl9odWRqSVlYU3h5djdWNjI1MkFVMnNESnVJ?oc=5" target="_blank">Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IYVhhNHo4QzE5UmFjN1F0bUp5b3Vmc1dadVQ3SUx1TF9nNE1WRU1VZWdvUnQ0N20yLUYtU0tyNURiNVhIdkZuOGo0RThFZDI5YWVCM0JOeDBjb2F2b240?oc=5" target="_blank">Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1JREsyTXl0aFR6bjFEQS1Lc2ppaXhEYl9sYUpNNHJoQXIxa3VaOFFmYWw4cDdSSFJzTmxDdDFvSmVJYnJzZzNaaElFNEs3VEtiVm9fdHFNdnJtaEtTMHhF?oc=5" target="_blank">Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xQ3RUb3lwWDFBUEpEb1ViNFVQV2pkZGJ6V0cwTXlSVjZwQnF6U3JRTnpxWVdMaXZrNHMzUGpLbmhkM043SEREWDBRN1E3UXFYR0FqV1ZGTDRTelJHT1pF?oc=5" target="_blank">Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models | Scientific Reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xMnROYURubGV6WklQVnF6TTBfQVJWV0FQOEF1UVJfM0Y1QWppdG5ZSnZvLVJkME5vQmFxUE1ZTzAwZFk0dXY5eUNjb3BpRTVVbTJmcFlfRWN1LUh1X05B?oc=5" target="_blank">Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1LbHJzV2prTXZDNGpDV2lHLXNMWjBubU81bTRfdnh3cjhlZDBQNkszZGVGbDg2VW9aYUplcTZReTFZaDNvTVVrYTNTZjkySmFFbGtYQXhwSGJ4dEtZanVaNA?oc=5" target="_blank">Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNlBHX0JVOE1ZSW5DeGtIVWU1MnJoWEtyNGRzM1F0eXRrS21QRTk5YVI0R09aYkx3Y2k0QWFwZ2k3TjVGWkxTVWR1dEF1SExXZDNDRVdFbVhzeWtzejlsaGJNUHpVOXFyaFNCNFVPZkpKcGRXYVNiaGxCTGZ1azF1dk5SODVud0luTW1R?oc=5" target="_blank">Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE40TGo3amlfcWhJV1diYzhFSndENDJ5QlNzXzRhcDNENGNHR0tJSzdqOEJRWi1oRE4wZHRfSE5yMXA5OHV3LW1NNkVaNk50czM2bGx5UWtFc2h3YkIzczdJ?oc=5" target="_blank">Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9wd0k2em5feGk2R0RQTnJXNEdFeDhNaFBGNWdfU3p4MWc2MjZpaGtfU0lLR3pvLU4yRF9LRWZjU0JVdnZjdVhJdHN0Y1hUNVpUaENzYlRlSjFYWGc3OU04?oc=5" target="_blank">Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8ybmJHM1pTanRMVWEtWVZYTTV5aC1RX1M3V0VXLW9nazYtR1NDc0xFZmNPN19lNjNIVnZXRUV5UXRpdGlNUWlGb2dKTk5iY3lnanhaeDExSW9EQmZ2US1j?oc=5" target="_blank">A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1qY3JBcy1yZlc1TE9nUnlLbHdWV05yeUNvN0E1X0RxWXhiZjAwVjZMRUFCZDZzOUt0WDlZeHZ3a1NUSWZHdTBKcHNzR2pkVXU2STIwMHBvTFY4cVR5MTlj?oc=5" target="_blank">A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines | npj Vaccines</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tOS1SZS1QLTZyd3NyMURVekM5VmJkTkxNTlVMOWN1dWNUT01iaWRWb2xpYkRPTEp1ckdiUEc2SlBHVF9zV2s2NlZhcEhEbnZqUHFaS2dGaTh1SGhRZ1lz?oc=5" target="_blank">Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1nV3dOM2VDRXFzS2JaQ0d2REtWS0QxQjBqSWpzRXhRV293WVhSZDFfbjhOS0ptTDlpZ2U3TnItU1UyVnFFU2VuY245YWFsT3RONm84MDFIWkNBcmpGODZF?oc=5" target="_blank">Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZWG5hckFkTHdoallMcUVNcHhEaFRiTEEyTUE1amE4czlqcG5mZERpNlQyY0V5NlJVZ3lBVW42b1BPa1V0NENYeXdjYWt3TzJpdUN3TFNhcDBzMlJCNzJr?oc=5" target="_blank">Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE15alZSaWx0enlNNGVYN01Ddi1VWkw0dWFRQktITG4zUHBnbmdKOUltTFJ4UUJLaGxUeGJ2aDdIcm5BcUVtWE5sZ0tTSmRqSm0wUHN2QVZNbERYNzNyOVpF?oc=5" target="_blank">Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>